Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ABIOMED, Inc. (ABMD : NSDQ)
 
 • Company Description   
Abiomed Inc. is engaged in developing, manufacturing and marketing of medical products, designed to assist or replace the pumping function of the failing heart.

Number of Employees: 1,725

 
 • Price / Volume Information   
Yesterday's Closing Price: $235.75 Daily Weekly Monthly
20 Day Moving Average: 377,710 shares
Shares Outstanding: 45.52 (millions)
Market Capitalization: $10,730.40 (millions)
Beta: 1.34
52 Week High: $379.30
52 Week Low: $226.46
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -25.31% -15.89%
12 Week -23.19% -15.56%
Year To Date -34.36% -18.81%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
22 CHERRY HILL DR
-
DANVERS,MA 01923
USA
ph: 978-646-1400
fax: 978-777-8411
ir@abiomed.com http://www.abiomed.com
 
 • General Corporate Information   
Officers
Michael R. Minogue - Chief Executive Officer;Chairman;President and Dir
Todd A. Trapp - Chief Financial Officer and Vice President
Dorothy E. Puhy - Director
Jeannine M. Rivet - Director
Eric A. Rose - Director

Peer Information
ABIOMED, Inc. (ABMD)
ABIOMED, Inc. (DMDS)
ABIOMED, Inc. (CPWY.)
ABIOMED, Inc. (EQUR)
ABIOMED, Inc. (ECIA)
ABIOMED, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 003654100
SIC: 3841
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/03/22
Share - Related Items
Shares Outstanding: 45.52
Most Recent Split Date: 10.00 (2.00:1)
Beta: 1.34
Market Capitalization: $10,730.40 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $4.62 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 19.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/03/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 51.08
Trailing 12 Months: 53.34
PEG Ratio: 2.69
Price Ratios
Price/Book: 7.14
Price/Cash Flow: 42.72
Price / Sales: 10.40
EPS Growth
vs. Year Ago Period: -6.45%
vs. Previous Quarter: 2.65%
Sales Growth
vs. Year Ago Period: 11.86%
vs. Previous Quarter: 3.32%
ROE
03/31/22 - 14.47
12/31/21 - 15.19
09/30/21 - 15.80
ROA
03/31/22 - 13.02
12/31/21 - 13.64
09/30/21 - 14.12
Current Ratio
03/31/22 - 7.05
12/31/21 - 6.98
09/30/21 - 7.64
Quick Ratio
03/31/22 - 6.37
12/31/21 - 6.27
09/30/21 - 6.89
Operating Margin
03/31/22 - 19.74
12/31/21 - 20.65
09/30/21 - 21.44
Net Margin
03/31/22 - 13.23
12/31/21 - 13.26
09/30/21 - 15.32
Pre-Tax Margin
03/31/22 - 18.47
12/31/21 - 18.87
09/30/21 - 21.79
Book Value
03/31/22 - 33.03
12/31/21 - 31.48
09/30/21 - 30.43
Inventory Turnover
03/31/22 - 2.13
12/31/21 - 2.14
09/30/21 - 2.12
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©